The TM6 facility is designed to deliver enhanced output, improved efficiency, and advanced environmental performance.
SAUDI ARABIA – Middle East Paper Company (MEPCO), through its tissue division Juthor, has reached a significant milestone with the groundbreaking of its second tissue production line, TM6, at King Abdullah Economic City near Jeddah.
The launch of the TM6 line marks a strategic move to scale up MEPCO’s manufacturing capacity while reinforcing its commitment to innovation, sustainability, and operational excellence.
The project aligns with Saudi Arabia’s Vision 2030 industrial transformation agenda and reflects MEPCO’s growing ambition to lead in both regional and global tissue markets.
“This project is not just an expansion of infrastructure—it’s an investment in the future of sustainable paper manufacturing in the region,” a company spokesperson said at the groundbreaking ceremony.
“The TM6 line reflects MEPCO’s ambition to lead in both operational excellence and environmental responsibility.”
With growing demand for tissue and hygiene products across the Middle East and beyond, the TM6 facility is designed to deliver enhanced output, improved efficiency, and advanced environmental performance.
MEPCO is responding with scalable, eco-conscious solutions that adhere to global standards, meeting the rising expectations of both consumers and regulators.
The facility will incorporate state-of-the-art technology and sustainable manufacturing practices to support MEPCO’s environmental objectives, such as resource efficiency and carbon footprint reduction.
These enhancements mirror wider industry trends in the paper and forest products sector, where companies are increasingly adopting low-waste, high-performance operations.
Once operational, TM6 is expected to make a substantial contribution to MEPCO’s total tissue output, strengthening its position in the competitive tissue production and eco-conscious packaging markets.
Construction of the TM6 line follows MEPCO’s signing of a contract last November with Austrian firm Andritz AG to manufacture, supply, and install the production system.
The agreement, announced on November 10, 2023, is valued at approximately SAR 216.7 million (USD 57.69 million), which represents no more than 25% of MEPCO’s 2023 total revenue of SAR 866.75 million (USD 230.76 million).
Spanning 24 months, the project will deliver a complete tissue production line with an annual capacity of 60,000 tonnes and a production speed of 2,100 meters per minute.
As work on TM6 begins, the facility is set to become a cornerstone of MEPCO’s growth strategy, supporting both domestic supply and international exports from one of the region’s most advanced industrial zones.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.